4:01 PM ET
8-K
M&A Deal
Neogen M&A Deal with Zoetis Inc.
Neogen Corporation provided a status update on the pending sale of its global Genomics business to Zoetis Inc. To facilitate regulatory clearance from the ACCC and NZCC, Zoetis has offered to divest certain assets in Australia, with the transaction now expected to close in early 2027.
- Counterparty
- Zoetis Inc.